Advertisement
Screener

Exome Asset Management LLC Historic Quarter Change: Foreign Stocks, Sold Out

Add as a preferred source on Google

Exome Asset Management LLC historic quarter change: Foreign Stocks, Sold out

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Exome Asset Management LLC opened 16 positions, added to 8, reduced 16 and sold out of 17.

  • Q1 2026: Stock IMCR; Country of operation —; Class ADS; Shares before 76,750.
  • Q1 2026: Stock BLTE; Country of operation United States; Class SPONSORED ADS; Shares before 14,328.
  • Q4 2025: Stock CNTA; Country of operation —; Class SPONSORED ADS; Shares before 88,024.
  • Q3 2025: Stock GPCR; Country of operation United States; Class SPONSORED ADS; Shares before 53,744.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 2011932), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-15); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-16); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-10-03); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2023-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026IMCR
IMMUNOCORE HLDGS PLC		ADS76,7500-76,750$2,663,993$0-$2,663,9932026-05-15
Q1 2026BLTE
BELITE BIO INC		United StatesSPONSORED ADS14,3280-14,328$2,291,907$0-$2,291,9072026-05-15
Q4 2025CNTA
CENTESSA PHARMACEUTICALS PLC		SPONSORED ADS88,0240-88,024$2,134,582$0-$2,134,5822026-02-13
Q3 2025GPCR
STRUCTURE THERAPEUTICS INC		United StatesSPONSORED ADS53,7440-53,744$1,114,651$0-$1,114,6512025-11-14
Q3 2025LEGN
LEGEND BIOTECH CORP		United StatesSPONSORED ADS29,1000-29,100$1,032,759$0-$1,032,7592025-11-14
Q3 2025CMPS
COMPASS PATHWAYS PLC		SPONSORED ADS213,5440-213,544$597,923$0-$597,9232025-11-14
Q2 2025ONC
BEIGENE LTD		SPONSORED ADS6,5000-6,500$1,769,105$0-$1,769,1052025-08-15
Q2 2025RDY
DR REDDYS LABS LTD		ADR117,5000-117,500$1,549,825$0-$1,549,8252025-08-15
Q1 2025ONC
BEIGENE LTD		SPONSORED ADR10,0000-10,000$1,847,100$0-$1,847,1002025-05-16
Q1 2025LEGN
LEGEND BIOTECH CORP		United StatesSPONSORED ADS37,6000-37,600$1,223,504$0-$1,223,5042025-05-16
Q4 2024BNTX
BIONTECH SE		SPONSORED ADS34,5520-34,552$4,103,741$0-$4,103,7412025-02-14
Q4 2024ADAG
ADAGENE INC		ADS262,6250-262,625$583,028$0-$583,0282025-02-14
Q3 2024AUTL
AUTOLUS THERAPEUTICS PLC		SPON ADS839,4720-839,472$2,921,363$0-$2,921,3632024-11-14
Q3 2024ZLAB
ZAI LAB LTD		ADR86,7000-86,700$1,502,511$0-$1,502,5112024-11-14
Q3 2024NBP
I MAB		SPONSORED ADS271,4000-271,400$453,238$0-$453,2382024-11-14
Q1 2024GPCR
STRUCTURE THERAPEUTICS INC		United StatesSPONSORED ADS68,1000-68,100$2,775,756$0-$2,775,7562024-05-15
Q1 2024LEGN
LEGEND BIOTECH CORP		United StatesSPONSORED ADS37,9000-37,900$2,280,443$0-$2,280,4432024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
waypoint wealth counselUnited States$0.193B350
Broadway Wealth Solutions, Inc.United States$0.193B95
Ayrshire Capital Management LLCUnited States$0.193B50
JACKSON HILL ADVISORS, LLCUnited States$0.193B13
Banque de Luxembourg S.A.Luxembourg$0.193B77
Topel & Distasi Wealth Management, LLCUnited States$0.193B58
Mitsubishi UFJ Asset Management (UK) Ltd.United Kingdom$0.193B96
Downshift Financial, LLCUnited States$0.193B77
BostonPremier Wealth LLCUnited States$0.194B70
Legal Advantage Investments, Inc.United States$0.194B79
Advertisement